近視(Myopia):治療薬開発パイプライン動向2015

調査会社DelveInsight社が発行したリサーチレポート(データ管理コード:DELVP501455)
◆英語タイトル:Myopia-Pipeline Insights, 2015
◆発行会社/調査会社:DelveInsight
◆商品コード:DELVP501455
◆発行日:2015年版(※最新版はお問い合わせください)
◆調査対象地域:グローバル
◆産業分野:製薬
◆ページ数:60以上
◆レポート言語:英語
◆レポート形式:PDF
◆納品方式:Eメール(納品まで約3営業日)
◆販売価格オプション(消費税別)
Single User(1名使用)USD1,250 ⇒換算¥141,250見積依頼/購入/質問フォーム
Site Price(同一国内共有可)USD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Enterprise Price(複数国内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
DelveInsight社の概要及び新刊レポートはこちらでご確認いただけます。

★グローバルリサーチ資料[近視(Myopia):治療薬開発パイプライン動向2015]についてメールでお問い合わせはこちら
本調査レポートでは、世界における近視(Myopia)の治療薬開発パイプライン動向について調査・分析し、企業別開発中の治療薬、各臨床試験段階における製品リスト及び比較分析、薬剤候補のプロファイル、治療薬の評価、開発中止又は開発休止中の製品リスト等をお届けしています。また、近視(Myopia)治療薬開発に取り組んでいる企業情報も提供しています。(※本レポートはご注文を頂いてから、最新データに更新して納品しているため、正確なページ数を明記しておりません。)

・近視(Myopia)の概要

・近視(Myopia)のパイプライン製品概要

・企業別開発中の治療薬

・後期治験段階の製品(Filed & Phase III):比較分析

・中期治験段階の製品(Phase II):比較分析

・初期治験段階の製品(Phase I & IND):比較分析

・前臨床段階の製品:比較分析

・薬剤候補のプロファイル

・近視(Myopia)治療薬の評価
  - 単剤治療薬
  - 併用治療薬
  - 投与経路別
  - 分子の種類別

・開発が中止された製品リスト

・開発休止中の製品リスト

・近視(Myopia)治療薬開発に取り組んでいる企業リスト

・図表一覧
*** レポート概要(サマリー)***

SUMMARY
DelveInsight’s,“ Myopia-Pipeline Insights, 2015”, report provides comprehensive insights about pipeline drugs across this indication. A key objective of the report is to establish the understanding for all the pipeline drugs that fall under Myopia. This report provides information on the therapeutic development based on the Myopia dealing with all the pipeline drugs, comparative analysis at various stages covering Filed, Phase III, Phase II, Phase I, IND filed, Preclinical, Discovery and unknown stages, therapeutics assessment by monotherapy and combination products and molecule type drug information. The report also covers the companies information involved in the therapeutic development of the products. It also has highlighted the discontinued and dormant products.

[Data Sources]

The report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by DelveInsight team of industry experts.

Secondary sources information and data has been collected from various printable and non-printable sources like search engines, News websites, Government Websites, Trade Journals, White papers, Magazines, Trade associations, Books, Industry Portals, Industry Associations and access to available databases.

Note*: This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated Indication.


Scope
• The report provides a snapshot of the global therapeutic landscape of Myopia
• The report provides pipeline products under drug profile section which includes product description, MOA, licensors & collaborators, development partner and chemical information
• Coverage of the Myopia pipeline on the basis of target, MOA, route of administration, technology involved and molecule type
• The report reviews key players involved in the therapeutics development for Myopia and also provide company profiling
• The report also gives the information of dormant and discontinued pipeline projects
• Pipeline products coverage based on various stages of development ranging from preregistration till discovery and undisclosed stages
• Provides pipeline assessment by monotherapy and combination therapy products, stage of development and molecule type


*** レポート目次(コンテンツ)***

Table of Contents
• Myopia Overview
• Myopia Pipeline Therapeutics
• Myopia Therapeutics under Development by Companies
• Myopia Late Stage Products (Filed and Phase III)
– Comparative Analysis
• Myopia Mid Clinical Stage Products (Phase II)
– Comparative Analysis
• Myopia Early Clinical Stage Products (Phase I and IND Filed)
– Comparative Analysis
• Myopia Discovery and Pre-Clinical Stage Products
– Comparative Analysis
• Drug Candidate Profiles
• Myopia – Therapeutics Assessment
– Assessment by Monotherapy Products
– Assessment by Combination Products
– Assessment by Route of Administration
– Assessment by Molecule Type
• Myopia – Discontinued Products
• Myopia – Dormant Products
• Companies Involved in Therapeutics Development for Myopia
• Appendix
• Methodology
• Contact Us
• Disclaimer

List of Tables
• Number of Products under Development for Myopia, 2015
• Number of Products under Development by Companies
• Comparative Analysis by Late Clinical Stage Products (Filed and Phase III), 2015
• Comparative Analysis Mid Clinical Stage Products (Phase II), 2015
• Comparative Analysis Early Clinical Stage Products (Phase I and IND Filed), 2015
• Comparative Analysis Discovery and Pre-Clinical Stage Products, 2015
• Drug Candidates Profiles
• Myopia Assessment by Monotherapy Products
• Myopia Assessment by Combination Products
• Myopia Assessment by Route of Administration
• Myopia Assessment by Stage and Route of Administration
• Myopia Assessment by Molecule Type
• Myopia Assessment by Stage and Molecule Type
• Myopia Therapeutics – Discontinued Products
• Myopia Therapeutics – Dormant Products
• Products under Development by Companies, 2015


List of Figures
• Number of Products under Development for Myopia, 2015
• Late Clinical Stage Products (Filed and Phase III), 2015
• Mid Clinical Stage Products (Phase II), 2015
• Early Clinical Stage Products (Phase I and IND Filed), 2015
• Discovery and Pre-Clinical Stage Products, 2015
• Myopia Assessment by Monotherapy Products
• Myopia Assessment by Combination Products
• Myopia Assessment by Route of Administration
• Myopia Assessment by Stage and Route of Administration
• Myopia Assessment by Molecule Type
• Myopia Assessment by Stage and Molecule Type


*** レポートのキーワード ***

近視(Myopia)、治療薬(医薬品、薬剤)、製薬企業、研究開発、治験、製品パイプライン

*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/


※おすすめ調査資料
  • Nephropathy:治療薬市場動向2014(市場規模、グローバルAPIメーカー、第Ⅲ相試験)
    DelveInsight’s, “ Nephropathy- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API M …
  • 樹状細胞がんワクチンの世界市場
    “Global Dendritic Cell Cancer Vaccine Market & Clinical Trials Outlook 2023” report gives comprehensive insight on various clinical and non-clinical advancements in the global dendritic cell cancer vaccine market. In recent years, dendritic cell cancer vaccines have emerged as new growth frontier fo …
  • 世界主要国における建材一体型太陽光発電(BIPV)市場2018-2023
    In 2017, the global Building Integrated Photovoltaic (BIPV) market size was xx million USD, and it will be xx million USD in 2023, with a CAGR of xx% between 2017 and 2023. This report studies Building Integrated Photovoltaic (BIPV) in Global market, especially in United States, Canada, Mexico, Germ …
  • 次世代ネットワークOSS/BSS市場および予測2015-2020
    Communication Service Providers (CSP) are adopting next generation OSS/BSS systems for many reasons including integration with new IP-based frameworks, emerging applications, and the need to continuously improve upon customer service and retention efforts. Other factors include the need for network …
  • 歯ブラシ及び替ブラシヘッド市場(~2017):チェコ
    Synopsis The report presents detailed data on consumption trends in the Toothbrushes and Replacement Heads category in Czech Republic, analyzing consumption volumes and values at segment level. It also provides indispensable data on distribution channels along with latest industry news and mergers a …
  • 背景抑制センサの世界市場2016
    Notes:Production, means the output of Background Suppression Sensor Revenue, means the sales value of Background Suppression Sensor This report studies Background Suppression Sensor in Global market, especially in North America, Europe, China, Japan, Korea and Taiwan, focuses on top manufacturers in …
  • ピレスリンエアロゾルの世界市場
    Pyrethrin Aerosol Report by Material, Application, and Geography – Global Forecast to 2021 is a professional and in-depth research report on the world's major regional market conditions, focusing on the main regions (North America, Europe and Asia-Pacific) and the main countries (United States, Germ …
  • レバノンの建築用プラスチック製品市場(~2019):市場規模、動向、予測
    The report Plastic Construction Product Market in Lebanon to 2019 - Market Size, Development, and Forecasts offers the most up-to-date industry data on the actual market situation, and future outlook for plastic construction products in Lebanon. The research includes historic data from 2008 to 2014 …
  • 公共建築物建設市場データ:韓国
    This report is the result of Timetric’s extensive market research covering the institutional buildings construction industry in South Korea. It contains detailed historic and forecast market value data for the institutional buildings construction industry, including a breakdown of the data by constr …
  • Energiekontor AG (EKT)(代替エネルギー分野):企業M&A動向
    Summary Energiekontor AG (EKT) is a wind energy service provider. The company develops and operates wind energy projects. It owns wind parks. EKT builds and operates 84 wind farms with 495 turbines with a total capacity of approximately 610 megawatts. The company concentrates in the planning, constr …
※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
※当市場調査資料(DELVP501455 )"近視(Myopia):治療薬開発パイプライン動向2015" (英文:Myopia-Pipeline Insights, 2015)はDelveInsight社が調査・発行しており、H&Iグローバルリサーチが販売します。


◆H&Iグローバルリサーチのお客様(例)◆


※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
※H&Iグローバルリサーチ(登録第5864124号)及びH&I(登録第5783645号)はH&Iグローバルリサーチ株式会社の商標です。